- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.02. | Sanofi moves closer to selling controlling stake in $17bn-valued Opella | ||
| 19.02. | Cumberland's Vibativ injection gains China's NMPA approval | ||
| 19.02. | Amazon joins forces with Memorial Sloan Kettering for AI-powered drug discovery | ||
| 19.02. | GLP-1RAs and opioid use disorder: a new frontier in addiction treatment | ||
| 19.02. | Biogen and Stoke Therapeutics to commercialise Dravet syndrome treatment | ||
| 19.02. | Can innovation in clinical trial delivery meet the demands of increasing complexity in drug development? | ||
| 19.02. | New CEOs to join Merck KGaA's executive board | ||
| 18.02. | Gilead's lenacapavir moves closer to FDA approval for HIV PrEP use | ||
| 18.02. | Valneva hits 2024 sales target but plans lower cash burn in 2025 | ||
| 18.02. | EC conditionally approves MSD's Welireg for VHL disease and RCC | ||
| 18.02. | FDA to review Sanofi and Regeneron's Dupixent sBLA for bullous pemphigoid | ||
| 18.02. | HMRI and Novartis Australia sign MoU to expedite medical research | ||
| 18.02. | FDA grants fast track status to Rznomics' RZ-001 for HCC | ||
| 17.02. | Ono's TGCT therapy wins FDA approval, challenging Daiichi Sankyo | ||
| 17.02. | Oncology and eClinical solutions: How one company is adapting to the challenges | ||
| 17.02. | Innate's lacutamab gains FDA breakthrough therapy designation | ||
| 17.02. | Bispecific antibody startup Bambusa raises $90m to fund clinical trials | ||
| 17.02. | Bavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teens | ||
| 17.02. | GSK's Penmenvy meningococcal vaccine gains FDA approval | ||
| 17.02. | Moderna reports decline in Q4 2024 revenue | ||
| 14.02. | EC approves CSL's Andembry to stop hereditary angioedema attacks | ||
| 14.02. | DMD market expected to grow to $5.2bn in the 7MM by 2033 | ||
| 14.02. | Galderma enters fierce European atopic dermatitis market with Nemluvio approval | ||
| 14.02. | EU reshapes HTAs: is the industry ready for it? | ||
| 14.02. | Newleos secures $93.5m for neuropsychiatric treatments |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
